Blood Services, Scottsdale, Arizona. The HLA gene cluster is known to be on chromosome 6. The distance between the centromere of chromosome 6 and the HLA gene cluster is, however, not known.
These tumors originate from a single female germ after first meiosis. Gene loci near the centromere which have not experienced recombination are homozygous, while genes further from the centromere which have experienced a recombinant event are heterozygous.
We have HLA-typed cells from two ovarian teratomas in tissue culture and compared their HLA types to data from lymphocytes and cultured normal cells from the same hosts. In both cases whenever the host had two HLA haplotypes, the teratoma cells had but one HLA haplotype and so was homozygous for HLA. This indicates no recombination between HLA and the centromere of 6 chromosome. Parthenogenic ovarian teratomas are thus a source of HLA-homozygous cells. The typing method is simple and will permit precise genetic mapping of the HLA gene cluster. This is the first use of parthenogenic human cells for immune gene mapping.
A NEW SYNDROME OF RETINITIS PIGMENTOSA, HEARING LOSS, MENTAL RETARDATION, AND DYSMORPHOLOGY, Jose h H. Two siblings born to nonconsanguinous parents were evaluated for mental retardation(MR).
Findings included retinitis pigmentosa(RP), sensorineural hearing loss(HL) and similar dysmorphism.
JA was 4% and LA was 2. There was delayed closure of the anterior fontanelle. Length and weight were 5th7 and OFC for JA was 50th% and LA was 20th%. They had frontal bossing, downslanting palpebral fissures, epicanthal folds, flattened nasal bridge, lowset ears, and small feet. JA had strabismus and LA had proptosis. JA had small externalia genitalia. Both had hypotonia and hearing loss. Mental ages were 19 and 9 months. Both had extinguished ERG'S, normal CT scans, amino acids, OGTT's and chromosomes. LA had normal skull films and thyroid studies. -facies, feet
Although our patients shared some of these features, the dysmorphology separates them and reflects a new recessive syndrome which should be added to this group.
AUTOSOMAL DOMINANT ANTERIOR SEGMENT DYSGENESIS WITH

73& VARIABLE EXPRESSIVITY: PROBABLE LINKAGE TO MNS BLOOD
' GROUP ON CHROMOSOME 4. Helen M. Hittner, Robert E. An autosomal dominant anterior segment dysgenesis (ADASD) with variable expressivity affecting members of at least eight generations was identified. One branch of the family involving five generations with 21 of 35 (60%) members affected was studied. This included sixteen affected (9 males and 7 females) who were still living. Clinical findings ranged from anterior Schwalbe's line with mild cataract to severe corneal opacification with moderate cataract while visual acuity varied from 20120 to hand motion only.
The propositus had a corneal transplant and cataract extraction on one eye at age 6 weeks. Light and electron microscopic analyses demonstrated that the cornea had the following abnormalities: basal epithelial cell protrusions into a thickened Bowman's layer (22-60p), activated keratocytes throughout the entire stroma, no Descemet's layer or endothelial cells, an aggregation of keratocytes posteriorly. The lens showed focal aggregations of vesicles in cortical fibers with extensive epithelial atrophy.
Maximum likelihood analysis between ADASD and 14 biochemical and serological markers showed probable linkage between ADASD and the MNS blood group on the long arm of chromosome 4 (Z = 3.48). Sister chromatid exchanges (SCE) are an indication of DNA damage, and the BrdU-labeling technique used to detect them constitutes a sensitive method for assaying the clastogenicity of various chemical agents. This method was used to investigate whether the drug phenytoin sodium (Dilantin), a commonly prescribed anticonvulsant, produces clastogenic effects. The frequency of SCE was determined in normal human lymphocyte chromosomes treated in vitro with various concentrations of phenytoin and differentially stained with acridine orange. The SCE frequency was significantly increased at 30 mcg/ml of phenytoin. SCE frequencies were also determined from lymphocyte cultures for six control subjects and for ten patients undergoing monotherapy with phenytoin for a maximum of eight years. Serum phenytoin levels ranged from 3.8 mcg/ml to 29.5 mcg/ml in the therapy group. There was no significant difference between the frequency of SCE in the phenytoin-treated patients and the control subjects. .aEalornia 92083. I-cell (MLII) fibroblasts have a high free-cystine (cys) content. As in cystinotic (C) cells, the cys is in lysosomes. In cystine-free media with ImM cysteamine, both cell types lose 50% of their cys in 6-9 min. The rate of loss changes with time, and by 60 min the decrease of cys is 88-97% in C cells but only 54-64% in MLII cells. Following removal of cystearnine and replacement with complete medium, cys reaccumulation in the first 8 h.is much greater in C cells (0.27-0.48 nmolfmg protfh.) than in MLII cells (0.02-0.04 nmol/mg/h,). From 8 to 24 h. the rates of reaccumulation of both cell types are similar (0.06 nmolfmgfh*.). Reaccumulation of cys in complete medium containing 30 mM glutathione-cysteine disulfide (GSSC) is increased 380% in C cells, but only 140% in MLII cells. With 50 p M chloroquine, the reaccumulation of cys in complete medium is inhibited in both cell types. Chloroquine does not inhibit the marked increase in cys reaccumulation with GSSC seen in C cells, but does in MLII cells. This suggests that the mechanism of cystine storage differs in the two cell types and that protein degradation is a more important source of cys in MLII than in C cells.
